Iradimed (IRMD) Free Cash Flow Growth (3y) (2016 - 2026)
Iradimed (IRMD) Free Cash Flow Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 128.94 Bn | 126.06 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 68.65 Bn | 67.19 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | -27.72% |
| 6 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | 77.20% |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn | -29.89% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.10 Bn | 21.98 Bn | 2.07 Bn | -0.27% |
| 10 | Iradimed | 1.22 Bn | 1.17 Bn | 16.81 Mn | 20.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.70% |
| Dec 31, 2025 | 26.50% |
| Sep 30, 2025 | 16.01% |
| Jun 30, 2025 | 52.16% |
| Mar 31, 2025 | -21.77% |
| Dec 31, 2024 | -2.96% |
| Sep 30, 2024 | 19.78% |
| Jun 30, 2024 | 15.72% |
| Mar 31, 2024 | 59.75% |
| Dec 31, 2023 | 56.96% |
| Sep 30, 2023 | -0.69% |
| Jun 30, 2023 | -76.57% |
| Mar 31, 2023 | 63.29% |
| Dec 31, 2022 | -10.60% |
| Sep 30, 2022 | 5.42% |
| Jun 30, 2022 | -15.11% |
| Mar 31, 2022 | 23.77% |
| Dec 31, 2021 | 0.32% |
| Sep 30, 2021 | 74.22% |
| Jun 30, 2021 | 31.25% |